FDX1 and neoplasm of testis: The highest frequency of FDX1 alterations (>3%) was observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), followed by nonseminomatous testicular tumor (NSGCT) and seminoma (SEMI) (Figure 2A).